Interview 17 Jul 2017 Pinning Down Elusive Targets: Interviewing the Co-Founder & CSO of Heptares …of GPCRs are activated by hormones,” said Marshall, “and endocrine diseases are an example of smaller indications where we can more easily take candidates through all the way to the… July 17, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2023 iNtRON looks to control colorectal cancer through microbiome iNtRON Biotechnology has announced that it has demonstrated the effectiveness of P18-BE3CRC using a cancer organoid model. P18-BE3CRC is a drug candidate from iNtRON Biotechnology’s PHAGERIA platform technology, which is… April 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships …central nervous system-focused pipeline, which consists of fusion proteins. The preclinical-stage biotech’s lead candidate is ILM01, a fusion protein that targets protein fragments called amyloid beta that are the hallmark… August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 OneThree Biotech completes build and optimization of AI model for RSV data …infection and then identify drugs that can effectively reverse those signatures with therapeutically meaningful benefits with a view to then adding such identified drugs to Poolbeg’s pipeline. Producing candidates quickly… June 27, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 18 Mar 2024 Will the US biotech funding surge trigger a renaissance in the global biotech industry? …drug candidates in advanced stages of development. The collective move towards IPOs by these companies, following a record high in 2021 and subsequent drop, suggests a cautious yet optimistic outlook… March 18, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2022 STORM Therapeutics doses first patient with drug targeting solid tumors …developing new small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases. The patient was dosed with STC-15, STORM’s clinical candidate. It is an orally bioavailable, highly… November 28, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2017 Norway Brings Another Cancer Vaccine to the Clinic …RAS mutations. TG02 is Targovax’s second vaccine candidate to enter the clinic. Its lead candidate TG01 has recently completed a Phase I/II trial in resected pancreatic cancer and showed off… April 20, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
In Depth 7 Oct 2025 AKIGAI takes EGFR inhibitors beyond cancer to treat neuropathic pain …rodent models do not reflect what’s happening in humans very well,” said Christian Kersten, co-founder of AKIGAI. Many candidate drugs show strong analgesic effects in rodents but then fall short… October 7, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Aug 2024 Six epigenetics companies making strides in 2024 …Storm’s lead candidate STC-15 is the first RNA methyltransferase inhibitor to enter the clinic. STC-15 inhibits METTL3, an RNA methyltransferase associated with cancer and other diseases. Phase 1 interim results… August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2020 Spanish Neurology Biotech Launches with €7.6M Series A …plans to target a number of different neurological conditions and has three small molecule candidate drugs it plans to develop. Its lead candidate, which is designed to target multiple sclerosis… May 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jan 2023 Aditxt forms Adimune to focus on immune modulation therapies …drug candidate, ADI-100, which we believe to be extremely promising.” GMP drug substances of the product candidate ADI-100 are slated to enter the product stability testing program in January 2023…. January 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Sep 2022 AION Labs launches AI startup to improve drug trials …efficacy and safety to improve the probability of success of drug candidates in clinical trials. OMEC.AI aims to build a next-generation computational platform that can both identify hidden safety liabilities… September 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email